REVELATION BIOSCIENCES, INC. Current Liabilities
REVELATION BIOSCIENCES, INC. (REVB) had Current Liabilities of $1.88 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Liabilities, Current $1.88M.
- 2026-03-31: Liabilities, Current $1.42M.
- 2025-12-31: Liabilities, Current $2.00M.
- 2025-09-30: Liabilities, Current $1.85M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.88M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.42M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $2.00M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $1.85M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.57M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $1.09M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $1.91M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $4.07M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $11.13M 10-Q/A · filed 2024-09-23 | |
| 2024-03-31 | $5.23M 10-Q/A · filed 2024-09-23 | |
| 2023-12-31 | $5.56M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $5.40M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $4.62M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $8.10M 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $4.45M 10-K/A · filed 2024-09-23 | |
| 2022-09-30 | $4.37M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $6.00M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $8.08M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $2.14M 10-K · filed 2023-03-30 | $5.49M 10-K · filed 2022-04-15 |
| 2021-09-30 | $3.74M 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $3.31M 10-Q · filed 2021-08-23 | |
| 2021-03-31 | $2.12M 10-Q · filed 2021-06-22 | |
| 2020-12-31 | $3.43M 10-K · filed 2022-04-15 | $33.77K 10-K · filed 2021-03-31 |
| 2020-09-30 | $336.25K 10-Q · filed 2020-11-16 | |
| 2019-12-31 | $26.31K 10-K/A · filed 2021-06-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |